An intervention for treating alcohol dependence: relating elements of Medical Management to patient outcomes with implications for primary care.
OBJECTIVE
Alcohol dependence, frequently seen in medical settings, is a major problem that affects the health and well-being of many individuals and their families. The purpose of this study was to examine the relationship between treatment outcomes and patient and clinician factors specifically associated with a medically oriented intervention given for the treatment of alcohol dependence. The intervention was developed for the National Institute on Alcohol Abuse and Alcoholism-sponsored COMBINE Study, a randomized controlled trial combining 2 medications, naltrexone and acamprosate, with Medical Management, with or without specialty alcohol treatment.


METHODS
We examined the effect of patient adherence to treatment (number of Medical Management visits, total minutes in treatment, alliance or therapeutic relationship with the clinician, patient satisfaction with treatment, and clinician adherence to the Medical Management protocol) on abstinence from alcohol, amount of heavy drinking, and clinical improvement during treatment.


RESULTS
More Medical Management visits attended and less total time spent in Medical Management treatment was associated with more days of abstinence from alcohol, reductions in heavy alcohol drinking, and a higher likelihood of clinical improvement. The patients' positive perceptions of their alliance with their clinician and their satisfaction with treatment was significantly associated with more days of abstinence from alcohol during treatment. Two clinician factors clinician confidence in the Medical Management treatment and flexibility in delivering Medical Management were also associated with better patient outcomes.


CONCLUSIONS
Medically trained clinicians with minimal specialty training in alcohol dependence treatments were able to deliver a brief and effective medication management intervention that was designed to be consistent with primary care practice.
Ernst
Denise B
DB
Center on Alcoholism, Substance Abuse, and Addiction, University of New Mexico, Albuquerque, NM 87106, USA. dernst@unm.edu
Pettinati
Helen M
HM
Weiss
Roger D
RD
Donovan
Dennis M
DM
Longabaugh
Richard
R
D000077443:Acamprosate; D000328:Adult; D000427:Alcohol Deterrents / Q000008:administration & dosage; D000437:Alcoholism / Q000188:drug therapy / Q000628:therapy*; D001521:Behavior Therapy / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009271:Naltrexone / Q000008:administration & dosage*; D010919:Placebos; D011320:Primary Health Care / Q000379:methods*; D013654:Taurine / Q000008:administration & dosage / Q000031:analogs & derivatives*
D000427:Alcohol Deterrents; D010919:Placebos; D013654:Taurine; D009271:Naltrexone; D000077443:Acamprosate
J Gen Intern Med. 2003 Jan;18(1):1-8
12534757
Arch Intern Med. 2001 Jan 8;161(1):85-91
11146702
JAMA. 2006 May 3;295(17):2003-17
16670409
Alcohol Clin Exp Res. 2003 Jul;27(7):1123-31
12878918
J Consult Clin Psychol. 1997 Aug;65(4):588-98
9256560
J Stud Alcohol Suppl. 1994 Dec;12:112-8
7722987
Alcohol Clin Exp Res. 2003 Oct;27(10):1680-5
14574241
JAMA. 2001 Oct 10;286(14):1715-23
11594896
Health Technol Assess. 1999;3(3):1-96
10448203
Arch Intern Med. 2003 Jul 28;163(14):1695-704
12885685
J Stud Alcohol Suppl. 2005 Jul;(15):170-8; discussion 168-9
16223068
Arch Intern Med. 1999 Sep 13;159(16):1946-52
10493326
Alcohol Clin Exp Res. 2003 Jul;27(7):1107-22
12878917
Am J Addict. 2002 Fall;11(4):291-307
12584872
Med Care. 2006 Apr;44(4):334-42
16565634